Endoscopic sphincterotomy for the treatment of recurrent pyogenic liver abscess

Abstract Not Availabl

Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum beta-lactamases

A practical approach to detect and identify ceftazidime-hydrolyzing extended-spectrum mutants of OXA-10 beta-lactamase is presented. Large numbers of bacteria were screened by colony hybridization, a 720-bp part of bla(OXA) was amplified by PCR from the hybridization-positive isolates, and the products were digested by PvuII and HaeIII

Dual-fed rectangular ring slotted patch antenna

Due to copyright restrictions, the access to the full text of this article is only available via subscription.In this work, a dual-fed rectangular ring slot patch antenna is designed and simulated. Compared to a common microstrip patch antennas, designed and simulated dual frequency patch antenna offers size reduction and higher gain. Simulation results showed input match of -11.77 dB at 4.1214 GHz and theta-polarized electric field gain of 8.26 dB at Θ = ± 20° at 4.1214 GHz.Sonnet Suite

THE DEMOGRAPHY AND PARTNER'S RELATIONSHIP OF PREMATURE EJACULATION IN TURKEY: MULTICENTER STUDY

WOS: 000282109300169

Increased H-FABP concentrations in nonalcoholic fatty liver disease: Possible marker for subclinical myocardial damage and subclinical atherosclerosis

Aim: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder which is reported as the hepatic manifestation of metabolic syndrome with an increased risk of cardiovascular events. Patients with NAFLD are also at risk of future cardiac events independently of metabolic syndrome. The aim of this study was to examine serum concentrations of heart type fatty acid binding protein (H-FABP) in NAFLD and to investigate its correlations with metabolic parameters and subclinical atherosclerosis. Patients and methods: A total of 34 patients with NAFLD and 35 healthy subjects were enrolled in the study. NAFLD patients had elevated liver enzymes and steatosis graded on ultrasonography. Healthy subjects had normal liver enzymes and no steatosis on ultrasonography. H-FABP levels were measured using an enzyme linked immunosorbent assay (ELISA) method and correlations with metabolic parameters and subclinical atherosclerosis were examined. Subclinical atherosclerosis was determined with carotid artery intima-media thickness (CIMT) which was measured by high resolution B mode ultrasonography. Results: H-FABP levels were elevated in patients with NAFLD (16.3 ± 4.0 ng/ml) when compared with healthy controls (13.8 ± 2.1 ng/ml; p 0.001). NAFLD patients had significantly higher CIMT than the controls had (0.64 ± 0.17 mm vs. 0.43 ± 0.14 mm, p = 0.009). The H-FABP concentrations were significantly positively correlated with body mass index (r = 0.255, p = 0.042), fasting blood glucose level (r = 0.300, p = 0.013), CIMT (r = 0.335, p = 0.043), and homeostasis model assessment-estimated insulin resistance (HOMA-IR; r = 0.156, p = 0.306). In multiple linear regression analysis, H-FABP levels were only independently associated with CIMT (p = 0.04) Conclusion: Serum H-FABP concentrations increase in patients with NAFLD. Our results may not only suggest that H-FABP is a marker of subclinical myocardial damage in patients with NAFLD but also of subclinical atherosclerosis, independent of metabolic syndrome and cardiac risk factors. © 2013 Urban ; Vogel

THE APPLICABILITY OF A PREMATURE EJACULATION PROFILE QUESTIONNAIRE FORMS IN OUR COUNTRY

WOS: 000282109300168